| Stock | Symbol | Price | Chart (24H) | Chart (5D) | 52 Week Range | Change % | Change | Open | Close | High | Low | Volume | Previous Close | Marketcap | Exchange | 52 Weeks High | 52 Weeks Low | Currency | Dividend Yield | Dividend Rate | EPS | Shares | Company | Industry | Type | Sector | Employees | City | State | Country | Phone | Address | Zip Code | Website | Last Updated |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Biogen Inc. BIIB | BIIB | $269.85 | -1.24% | $3.39 | $273.00 | $273.24 | $275.61 | $269.50 | 1.12M | $273.24 | $41.11B | NMS | $363.92 | $223.25 | USD | 24.8 | 153.88M | Biogen Inc. | Drug Manufacturers—General | EQUITY | Healthcare | 7.40K | Cambridge | MA | United States | 617 679 2000 | 225 Binney Street | 02142 | http://www.biogen.com | 3 hours ago |